Quantitative proteomic mass spectrometry of protein kinases to determine dynamic heterogeneity of the human kinome
Michael P. EastiD, Robert W. SprungiD, Denis O. OkumuiD, J. Felix Olivares-Quintero, Chinmaya U. JoisaiD, Xin Chen, Qiang ZhangiD, Petra Erdmann-GilmoreiD, Yiling MiiD, Noah Sciaky, James P. MaloneiD, Sonam BhatiaiD, Ian C. McCabeiD, Yi XuiD, Matthew D. SutcliffeiD, Jingqin Rosy LuoiD, Patricia A. SpearsiD, Charles M. PerouiD, Henry Shelton EarpiD, Lisa A. CareyiD, Jen Jen YehiD, David L. SpectoriD, Shawn M. GomeziD, Philip M. SpanheimeriD, R. Reid TownsendiD, Gary L. JohnsoniD
Abstract
The kinome is a dynamic system of kinases regulating signaling networks in cells and dysfunction of protein kinases contributes to many diseases. Regulation of the protein expression of kinases alters cellular responses to environmental changes and perturbations. We configured a library of 672 proteotypic peptides to quantify >300 kinases in a single LC-MS experiment using ten micrograms protein from human tissues including biopsies. This enables absolute quantitation of kinase protein abundance at attomole-femtomole expression levels, requiring no kinase enrichment and less than ten micrograms of starting protein from flash-frozen and formalin fixed paraffin embedded tissues. Breast cancer biopsies, organoids, and cell lines were analyzed using the SureQuant method, demonstrating the heterogeneity of kinase protein expression across and within breast cancer clinical subtypes. Kinome quantitation was coupled with nanoscale phosphoproteomics, providing a feasible method for novel clinical diagnosis and understanding of patient kinome responses to treatment.
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 3
- Organism
- Assay
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Kinase Inhibitor Pulldown Assay (KiP) for Clinical Proteomics
A. B. Saltzman, D. Chan, … M. J. Ellis·bioRxiv·Oct 13, 2022
- Phosphoproteomics-based Profiling of Kinase Activities in Cancer Cells
Jakob Wirbel, Pedro Rodriguez Cutillas, Julio Saez-Rodriguez·bioRxiv·Jul 26, 2016
- Proteomic Sensors for Quantitative, Multiplexed and Spatial Monitoring of Kinase Signaling
William J. Comstock, M.V.A.S. Navarro, … Marcus Bustamante Smolka·Nature CommunicationsPeer-reviewed·Nov 13, 2025
- Analysis of the human kinome and phosphatome reveals diseased signaling networks induced by overexpression
Xiao‐Kang Lun, Damian Szklarczyk, … Bernd Bodenmiller·bioRxiv·May 8, 2018
- diaPASEF-Powered Chemoproteomics Enables Deep Kinome Interaction Profiling
Kathryn Woods, Alexandria M. Chan, … Martin G. Golkowski·Journal of Proteome ResearchPeer-reviewed·Aug 27, 2025
- Chemical proteomics decrypts the kinases that shape the dynamic human phosphoproteome
Florian P Bayer, Julian Müller, … Bernhard Küster·bioRxiv·Nov 18, 2025